BioCentury
ARTICLE | Company News

Warner Chilcott musculoskeletal news

May 7, 2012 7:00 AM UTC

Warner Chilcott's board confirmed that it's conducting a process to explore strategic alternatives to enhance shareholder value, which include preliminary discussions for a sale. The company said it does not intend to disclose further developments regarding the process unless and until its board approves a specific course of action or otherwise deems further disclosure is appropriate or required. Goldman Sachs is advising Warner Chilcott. ...